Status: Recruiting
Efficacy and Safety Evaluation of Vi-sealer
This study's primary goal is to compare the efficacy and safety of the novel advanced hemostatic device(AHD), Vi-Sealer, with conventional AHDs in laparoscopic total hysterectomy for patients with benign gynecologic neoplasm.
Participants needed: 280
Trial details
Age: 20-65Biological sex: FemaleType: InterventionalSponsor: Hyun ParkUpdated: Oct 1, 2024Locations: 1
Eligibility criteria
Aged 20 to 65 years [+3]
Large uterus size over 16 weeks of gestational age [+6]